DNA testing
Search documents
DNA on gloves found near Nancy Guthrie’s home identified
NBC News· 2026-03-05 05:34
with an update in the disappearance of Nancy Guthrie, who's now been missing for 32 days. The Pima County Sheriff revealing a pair of gloves found a couple miles from NY's home like these were traced to a restaurant worker not connected to the crime. The investigation is looking into several other pieces of evidence sent to a lab for DNA testing. ...
Gloves, other evidence sent for testing in Guthrie case
NBC News· 2026-02-13 04:01
Investigators back outside Nancy Guthri's home, erecting this white pop-up tent on the front porch, the very place where NY's nest camera captured those chilling surveillance images the night she disappeared. Inside the tent, they were working and measuring to create the profile of the suspect. The Puma County Sheriff's Department says investigators casing the foothills around NY's neighborhood have now recovered several items of evidence, including gloves, which have been submitted for DNA testing. The New ...
Precision isn't precise without us | Dr.Majd Abdulghani | TEDxRiyadh
TEDx Talks· 2025-09-15 15:16
Precision Health & Genetic Data - Precision health has the potential to personalize prevention and treatment based on DNA patterns [9] - Current genetic data and models are overwhelmingly based on people of European ancestry, around 80% of the data, with Arabs making up less than 1% [9] - Lack of diverse genetic data creates borders in care, limiting the precision and effectiveness of medical treatments for underrepresented populations [9][10] - Genetic prediction models are not destiny but patterns, similar to weather forecasts, that can help prepare for potential health risks like diabetes, heart disease, and cancer [12][13] - The accuracy of prediction models decreases when applied to individuals with genetic backgrounds different from the data used to train the model [14] - Using genetics to inform prevention and treatment is already part of medical guidelines and clinical practice, but these are based on limited data [15][16] Saudi Arabia's Potential Role - Saudi Arabia is uniquely positioned to lead the transformation in precision health due to its young, tech-savvy population, leadership, healthcare vision, and integrated healthcare system [17] - Participation in research studies within Saudi Arabia is crucial to include Saudi, Gulf, and Arab data sets in prediction models and clinical decisions [18] - Saudi Arabia's genetic diversity, through its population and the millions of visitors to Mecca, can contribute to making medicine more precise for everyone [19] Call to Action - Breaking the boundary of who gets precision health is not a luxury but a necessity for life-saving decisions and accuracy in medicine [16][17] - The goal is to include the full spectrum of human genetic diversity in data sets to improve medicine for all populations [18][19]
23andMe's founder Anne Wojcicki wins bid for bankrupt DNA testing firm
New York Post· 2025-06-13 21:07
Core Insights - Anne Wojcicki is set to regain control of 23andMe after a $305 million bid from a nonprofit she controls, surpassing Regeneron Pharmaceuticals' previous offer of $256 million in a bankruptcy auction [1][2] - The deal is expected to close soon, pending a court hearing scheduled for June 17 [1] - 23andMe filed for bankruptcy in March due to declining demand and a data breach in 2023 that compromised sensitive customer information [2][6] Company Developments - 23andMe's bankruptcy filing was a result of a significant decline in consumer demand for DNA testing services [2][6] - The company faced legal challenges, with New York and over two dozen other states suing to contest the sale of its customers' private information [3] - TTAM Research Institute, associated with Wojcicki, has committed to upholding 23andMe's existing privacy policies and complying with data protection laws [2] Competitive Landscape - Regeneron Pharmaceuticals initially offered $256 million for 23andMe, which was later outbid by Wojcicki's nonprofit [1][5] - Regeneron expressed willingness to make a new bid but requested a $10 million breakup fee if Wojcicki's bid is accepted [5]